Clinical studies recruiting near Winnipeg

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Health Sciences Centre Winnipeg · Joseph Broderick, MD · NCT07227246 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · CancerCare Manitoba ( Site 0411) · Merck Sharp & Dohme LLC · NCT06393374 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · CancerCare Manitoba · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · CancerCare Manitoba · National Cancer Institute (NCI) · NCT05099003 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · CancerCare Manitoba · National Cancer Institute (NCI) · NCT06172296 UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
Phase N/A · Children's Hospital Health Science Centre Winnipeg · The Hospital for Sick Children · NCT06560606 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · CancerCare Manitoba · PedAL BCU, LLC · NCT05183035 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · CancerCare Manitoba · Children's Oncology Group · NCT06368817 Randomization of Single vs Multiple Arterial Grafts
NA · St. Boniface General Hospital / WHRA · Weill Medical College of Cornell University · NCT03217006 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · CancerCare Manitoba · National Cancer Institute (NCI) · NCT05691478 Dialectal Behaviour Therapy to Enhance Health Behaviour Change for Adolescents Living With Obesity (DIRECTION Trial)
NA · University of Manitoba · University of Manitoba · NCT05338944 A Platform Trial for Gram Negative Bloodstream Infections
NA · Grace Hospital · Sunnybrook Health Sciences Centre · NCT06537609 Investigating the Efficacy of an Augmented Virtual Reality Driving Simulator on Institutionalized Dementia Patients
NA · Riverview Health Center · University of Manitoba · NCT06419257 Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer
NA · Manitoba Prostate Centre, CancerCare Manitoba · Albany Medical College · NCT06517901 Selinexor and Backbone Treatments of Multiple Myeloma Patients
Phase 1/Phase 2 · Cancer Care Manitoba · Karyopharm Therapeutics Inc · NCT02343042 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · CancerCare Manitoba · Children's Oncology Group · NCT04322318 A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Phase 2 · Health Sciences Centre Winnipeg · Pfizer · NCT07470879 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Cancer Care Manitoba · Loxo Oncology, Inc. · NCT05254743 Canada-wide Implementation of a Virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patie
Phase N/A · Men's Health Clinic Manitoba · University Health Network, Toronto · NCT06877598 CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
NA · St. Boniface Hospital · University of Manitoba · NCT05726526 Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma
Phase 2/Phase 3 · Men's Health Clinic · Peter Black · NCT06124976 Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing
NA · Saint Boniface · University of British Columbia · NCT04634240 Type 1 Diabetes, Exercise and Mentoring Trial
NA · the Children's Hospital Research Institute of Manitoba and t · University of Manitoba · NCT06296992 Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Mu
Phase 3 · CancerCare Manitoba · Canadian Cancer Trials Group · NCT06182774 SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma
Phase 1/Phase 2 · Winnipeg Health Science Center · CHU de Quebec-Universite Laval · NCT02350205 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 The Role of Pulsed Dye Laser Therapy in the Management of Burn Scars
NA · University of Manitoba · University of Manitoba · NCT01488240 A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · FIN-11006, Winnipeg, MB · Colorado Prevention Center · NCT06033950 TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients
Phase 3 · Transplant Manitoba, adult · University of Sydney · NCT06474273 A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atop
Phase 3 · Manitoba Allergy Research Inc. · Organon and Co · NCT07265479

Look up another city

Look up another condition